Zacks Investment Management Acadia Pharmaceuticals Inc Transaction History

Zacks Investment Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$22.47 - $32.33 $704,883 - $1.01 Million	-31,370 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $370,230 - $539,897	13,794 Added 78.48%	31,370 $945,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $518,316 - $674,391	17,576	17,576 $662,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.64B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.